Tag: harm-reduction

  • CVA Urges Education Over Prohibition as Youth Vaping Declines

    CVA Urges Education Over Prohibition as Youth Vaping Declines

    The Canadian Vaping Association (CVA) is calling on federal and provincial health ministers to prioritize youth prevention and education programs over restrictive vaping bans, warning that prohibitionist policies could fuel the illicit market and push adult smokers back to cigarettes. CVA President Sam Tam said measures such as flavor bans would undermine harm-reduction efforts that have helped millions quit smoking, noting that tobacco use remains the leading cause of preventable death in Canada. The group emphasized that prohibition “leaves adult smokers with nowhere to turn except back to tobacco use,” threatening Canada’s goal of reducing smoking rates below 5% by 2035.

    Citing new Statistics Canada data, the CVA said youth vaping rates among Canadians aged 12–17 have fallen to 7.2% in 2025, nearly half the 2019 peak, crediting education-focused initiatives such as Health Canada’s “I Quit for Me” program. The association also highlighted research showing that flavored vaping products are crucial in helping adults switch from cigarettes, referencing studies by McGill University, Public Health England, and the Public Health Agency of Canada. The CVA warned that banning legal, regulated products would drive consumers to the black market, where unregulated, high-strength nicotine products are easily accessible to youth. Instead, the group urged governments to back evidence-based regulation, support enforcement, and expand youth cessation resources rather than pursuing prohibitionist approaches.

  • PMI Urges FDA to Educate Doctors on Harm-Reducing Alternatives

    PMI Urges FDA to Educate Doctors on Harm-Reducing Alternatives

    A new white paper from Philip Morris International U.S. (PMI U.S.) warns that many American healthcare providers misunderstand nicotine and tobacco harm reduction, limiting their ability to advise patients on safer alternatives to smoking.

    Survey results cited in the report show that half of medical professionals incorrectly believe nicotine causes cancer, while most are unaware which products are FDA-authorized for reduced harm. The paper stresses that the real health risks come from tobacco combustion, not nicotine itself, and switching to FDA-reviewed smoke-free products can significantly reduce harm for adults who continue to use nicotine.

    PMI U.S. calls on the FDA to actively educate providers, noting that 93% of surveyed doctors want guidance on lower-risk products and 95% would share it with patients. The report highlights that the U.S. is falling behind other countries in offering scientifically validated smoke-free options and emphasizes the need for science-based policy in tobacco harm reduction.

    The white paper is available here.

  • Former Tory Contender to Work for BAT

    Former Tory Contender to Work for BAT

    The Guardian reported today (April 10) that Penny Mordaunt, the former U.K. Conservative leadership contender who served in cabinet roles from defense secretary to leader of the House of Commons, has taken a job advising British American Tobacco’s (BAT) “transformation advisory group” on harm-reduction.

    Mordaunt’s new job was revealed by the Advisory Committee on Business Appointments, which said she should not lobby the government for two years after leaving office or advise on any public contracts.

    In its analysis, the committee said, “British American Tobacco has a significant interest in government policy and regulation and has resources focused on influencing government decisions – for example lobbying for a reduction in taxes for cigarettes, legislation on vaping and the prevention of counterfeit goods.”

    The committee said there were only limited risks associated with Mordaunt’s access to information that could help BAT given the change of government and the amount of time that had passed.

    However, it added: “Whilst you said you will not lobby, there is a risk your former role as a cabinet minister will be seen to offer British American Tobacco unfair access to and influence within government. Therefore, the committee’s advice is that you should have no direct engagement with government on behalf of the company, as to do so would raise significant risks under the government’s rules.”

    When asked about Mordaunt’s role, BAT chief corporate officer Kingsley Wheaton said, “BAT has launched a manifesto for change … it is founded on the very best tobacco harm reduction [THR] thinking and science. To accelerate that ambition, we understand alternative viewpoints that challenge our thinking will maximize success. This THR advisory board is designed to do just that.”

  • Sweden Wants Others to Follow its Harm-Reduction Success

    Sweden Wants Others to Follow its Harm-Reduction Success

    Sweden is boasting about its success with tobacco harm-reduction and is encouraging our countries to follow suit. Only 4.5% of Swedish-born adults smoke cigarettes which, according to the government, is owed to its policies that push safer alternatives like snus, nicotine pouches, and vapes.

    “Swedes have participated in a long-running harm reduction experiment, providing undeniable proof that replacing smoking with smokeless nicotine dramatically reduces smoking-related disease, disability and premature deaths – a net gain for public health, while reducing expenditure,” said Dr. Delon Human, leader of Smoke Free Sweden. “With harm reduction now policy in Sweden, every public health decision will reflect this approach. Other countries should adopt Sweden’s model without further delay.”

    Sweden’s Parliament formally adopted harm-reduction as a policy in December 2024, saying “Tobacco policy must consider the varying harmful effects of different products. Cigarettes pose a greater health hazard than smokeless nicotine… This must be reflected in taxation and policy goals.”

    Sweden has already applied risk-based taxation by lowering excise tax on snus while increasing it on cigarettes.